FITLIFE BRANDS INC
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 4. MINE SAFETY DISCLOSURES
None.
-13-
Part II
Our Common Stock was approved for listing and has traded since September 18, 2023 on the Nasdaq Capital Market under the symbol “FTLF”. Prior to September 18, 2023, our Common Stock traded in the over-the-counter market.
As of December 31, 2023, there were 4,598,241 shares of Common Stock outstanding and 22 shareholders of record of the Company’s Common Stock, in addition to an undetermined number of holders whose shares are held in “street name.”
The following table sets forth the high and low closing prices for our Common Stock for the periods indicated:
| High | Low | |
|---|---|---|
| First Quarter (January - March 2023) | $19.19 | $15.50 |
| Second Quarter (April - June 2023) | $17.25 | $15.50 |
| Third Quarter (July - September 2023) | $19.32 | $15.28 |
| Fourth Quarter (October - December 2023) | $22.45 | $18.62 |
| First Quarter (January - March 2022) | $16.70 | $11.80 |
| Second Quarter (April - June 2022) | $11.10 | $9.50 |
| Third Quarter (July - September 2022) | $16.80 | $10.25 |
| Fourth Quarter (October - December 2022) | $17.00 | $14.05 |
On March 28, 2024, the closing price of our Common Stock was $23.81 per share.
Recent Sales of Unregistered Securities
No unregistered securities were issued during the fiscal year.
Share Repurchase Program
On August 16, 2019, the Company approved a share repurchase program, pursuant to which the Board authorized management to repurchase up to $500,000 of the Company's Common Stock over the subsequent 24 months (the "Share Repurchase Program"), as amended September 23, 2019 to increase the repurchase amount to $1,000,000, and include shares of the Company's Common Stock, its Series A Convertible Preferred Stock, par value $0.01 per share ("Series A Preferred"), and warrants to purchase shares of the Company's Common Stock ("Warrants") in the Share Repurchase Program, to be repurchased over the next 24 months, at a purchase price, in the case of Common Stock, equal to the fair market value of the Company's Common Stock on the date of purchase, and in the case of Series A Preferred and Warrants, at a purchase price determined by management, with the exact date and amount of such purchases to be determined by management; further amended on November 6, 2019 to increase the repurchase amount to $2,500,000 over the subsequent 24 months, and further amended on February 1, 2021 to increase the repurchase amount to up to $5,000,000 over the subsequent 24 months.
On March 17, 2023, the Board approved an extension of the Share Repurchase Program. Under the extended and amended Share Repurchase Program, the Board authorized management to repurchase up to $5,000,000 of the Company's Common Stock over the subsequent 24 months, at a purchase price equal to the fair market value of the Company's Common Stock on the date of purchase, with the exact date and amount of such purchases to be determined by management. All other terms of the Share Repurchase Program remain unchanged.
During the year ended December 31, 2023, the Company did not repurchase any shares of the Company’s Common Stock under the Share Repurchase Program. As of December 31, 2023, the Company may purchase up to $5,000,000 of additional shares of Common Stock under the Share Repurchase Program.
-14-
Common Stock repurchase activity under our publicly announced Share Repurchase Program during each quarter of 2023 and 2022 was as follows:
| Trade date | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced programs | Dollar value of shares that may yet be purchased |
|---|---|---|---|---|
| First quarter ended March 31, 2022 | - | - | - | $3,169,917 |
| Second quarter ended June 30, 2022 | - | - | - | $3,169,917 |
| Third quarter ended September 30, 2022 | - | - | - | $3,169,917 |
| Fourth quarter ended December 31, 2022 | 48,596 | $15.86 | 48,596 | $2,398,979 |
| Subtotal | 48,596 | 48,596 | $2,398,979 | |
| First quarter ended March 31, 2023 | - | - | - | $5,000,000 |
| Second quarter ended June 30, 2023 | - | - | - | $5,000,000 |
| Third quarter ended September 30, 2023 | - | - | - | $5,000,000 |
| Fourth quarter ended December 31, 2023 | - | - | - | $5,000,000 |
| Subtotal | - | - | - | $5,000,000 |
Transfer Agent
Our transfer agent and registrar for the Common Stock is Colonial Stock Transfer located in Sandy, Utah.
Securities Authorized for Issuance under Equity Compensation Plans
For a discussion of our equity compensation plans, please see Item 11 of this Annual Report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.